The activation of MMP-9 pathway has been demonstrated in APOE4 transgenic mice [65], in APOE4 knock-in mice following TBI [71], in APOE4 knock-in mice crossed with 5 × FAD mice [70], as well as in AD patients with the APOE4 genotype [72]. Here, MMP9 is linked to Alzheimer disease.